Ignite Creation Date:
2025-12-25 @ 5:06 AM
Ignite Modification Date:
2026-05-26 @ 1:52 PM
Study NCT ID:
NCT05594927
Status:
RECRUITING
Last Update Posted:
2024-08-07
First Post:
2022-10-17
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Icaritin Soft Capsule Versus Huachansu Tablet in the First-line Treatment of Unresectable Hepatocellular Carcinoma With Poor Conditions and Biomarker Enrichment (Biomarker Enrichment Study of Poor Prognosis HCC Patients, BESTPOP)
Sponsor:
Beijing Shenogen Biomedical Co., Ltd
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
SNG2111-ICR-1
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None